Dr Reddys Laboratories RDY
NYSE RDY
$14.84 -0.07 (-0.50%)
As of: Nov 9, 2026 · 9:46 AM EST

Dr Reddys Laboratories (RDY) Net Preferred Shares Issued and Repurchased (2019 - 2026)

Updated

Dr Reddys Laboratories (RDY) reported Net Preferred Shares Issued and Repurchased of $711,426 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 32.6% from $1.05 million a year earlier and down 72.8% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Net Preferred Shares Issued and Repurchased (2019 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Dr Reddys Laboratories' Net Preferred Shares Issued and Repurchased came in at $6.68 million, up 27.9% year-over-year; for FY2026 (ended Mar 31, 2026), it was $4.5 million, up 124.9% from FY2025.

  • Net Preferred Shares Issued and Repurchased has a five-year compound annual growth rate of 2.4% (FY2021 to FY2026).
  • By fiscal year, Net Preferred Shares Issued and Repurchased came in at $2 million in FY2025 (-80.0%), $10 million in FY2024 (+400.0%), $2 million in FY2023 (-50.0%) and $4 million in FY2022 (unchanged).
  • The fiscal Q2 2027 figure ranks as the lowest quarterly Net Preferred Shares Issued and Repurchased since fiscal Q1 2025.
  • Year over year, Net Preferred Shares Issued and Repurchased gained in two of the last four quarters, with growth averaging 212.8%.
  • The high point for year-over-year Net Preferred Shares Issued and Repurchased in five years was fiscal Q1 2026 (growth of 905.5%); the low point was fiscal Q3 2024 (a decline of 89.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,225.92 Bn 1,199.53 Bn 20.46 Bn -
2 Johnson & Johnson 669.87 Bn 589.73 Bn 17.30 Bn -
3 AbbVie 514.17 Bn 482.18 Bn 13.12 Bn -
4 Merck 363.03 Bn 325.97 Bn 13.19 Bn -
5 Novartis Ag 314.10 Bn 287.34 Bn - -
6 Astrazeneca 290.83 Bn 264.72 Bn 13.26 Bn -
7 Amgen 247.70 Bn 199.36 Bn 7.58 Bn -
8 Gilead Sciences 206.67 Bn 181.78 Bn 6.73 Bn -
9 Pfizer 166.55 Bn 113.91 Bn 12.56 Bn -
10 Dr Reddys Laboratories 12.37 Bn 11.71 Bn 472.93 Mn 711,425.74
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 711,425.74
Jun 30, 2026 2.62 Mn
Sep 30, 2025 1.05 Mn
Jun 30, 2025 2.29 Mn
Sep 30, 2024 1.65 Mn
Jun 30, 2024 227,766.49
Mar 31, 2024 373,288.03
Dec 31, 2023 108,089.07
Sep 30, 2023 8.30 Mn
Jun 30, 2023 961,561.37
Mar 31, 2023 121,648.52
Dec 31, 2022 986,574.04
Sep 30, 2022 438,996.75
Jun 30, 2022 402,021.49
Mar 31, 2022 106,392.59
Dec 31, 2021 600,596.85
Sep 30, 2021 1.81 Mn
Jun 30, 2021 1.99 Mn
Mar 31, 2021 274,297.52
Dec 31, 2020 974,844.50
API Access

Dr Reddys Laboratories Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=RDY&period=max&api_key=YOUR_API_KEY